Relapses in the treatment of genotype 2 viral hepatitis C, a cause of concern in the blacks

Springer Science and Business Media LLC - Tập 33 - Trang 292-292 - 2013
O. Njoya1, L. Ntchama1, M. Tagni1, I. Dang1, M. Kowo1
1Department Gastroenterology, Réseau Camerounais de Lutte Contre Hépatite Virales, Yaoundé, Cameroon

Tài liệu tham khảo

Njouom R, Pasquier C, Ayouba A, et al. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of rain forest of south Cameroon. J Med Virol. 2003;71:219–25. Hézode C, Pawlotsky JM, Dhumeaux D. Traitement de l’hépatite chronique C. In: Pawlotsky JM, Dhumeaux D, (eds). Hépatite C. Paris: EDK; 2004. p. 206–25. Njouom R, Sartre MT, Timba I, et al. Efficacy and safety of peg interferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C. J Med Virol. 2008;80:2079–85.